HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.

Abstract
Three L1210 murine leukemia variants resistant to cisplatin, tetraplatin or carboplatin were compared with their sensitive parent line for differences in platinum accumulation, efflux and glutathione (GSH) content. All three resistant lines had reduced platinum accumulation compared with the sensitive line following exposure to each of the three drugs. There was no difference in the efflux of platinum between the sensitive and resistant lines indicating that reduced platinum accumulation was due to impaired uptake mechanisms. However, in cell survival experiments it was apparent that the resistant lines could tolerate higher intracellular platinum levels than the sensitive line. Intracellular GSH measurements revealed comparable levels in all but the L1210/carboplatin line which had a 2-fold elevation during the first 24 hours of culture. However, depletion of intracellular GSH with buthionin sulphoximine over a 72 hour period did not sensitize the resistant lines to the drugs. These studies have demonstrated that impaired platinum uptake is one of the mechanisms contributing to platinum drug resistance, while perturbations in GSH levels do not appear to play a role in these cell lines.
AuthorsM C Nicolson, R M Orr, C F O'Neill, K R Harrap
JournalNeoplasma (Neoplasma) Vol. 39 Issue 3 Pg. 189-95 ( 1992) ISSN: 0028-2685 [Print] Slovakia
PMID1528325 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Platinum
  • Carboplatin
  • Glutathione
  • Cisplatin
  • ormaplatin
Topics
  • Animals
  • Antineoplastic Agents (pharmacokinetics)
  • Carboplatin (pharmacokinetics, pharmacology)
  • Cisplatin (administration & dosage, pharmacokinetics)
  • Drug Resistance
  • Glutathione (metabolism)
  • Leukemia L1210 (drug therapy, metabolism)
  • Mice
  • Organoplatinum Compounds (pharmacokinetics, pharmacology)
  • Platinum (pharmacokinetics)
  • Sensitivity and Specificity
  • Tumor Cells, Cultured (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: